Mitral regurgitation

Minerva Cardioangiologica

Volumn 51, Issue 1, 2003, Pages 29-39

  Keeffe, B G ^a   Otto, C M ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Division of Cardiology   (United States)

Author keywords

Mitral valve insufficiency, diagnosis; Mitral valve insufficiency, etiology; Mitral valve insufficiency, therapy

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDRALAZINE; VASODILATOR AGENT;

ADULT; ANGIOGRAPHY; CASE REPORT; CHORDA TENDINEA; CHRONIC DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; DISEASE COURSE; ECHOCARDIOGRAPHY; HEART AFTERLOAD; HEART ATRIUM; HEART LEFT VENTRICLE; HEART PAPILLARY MUSCLE; HEART SURGERY; HUMAN; INCIDENCE; MALE; MITRAL VALVE DISEASE; MITRAL VALVE REGURGITATION; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; PLASTIC SURGERY; REVIEW; TREATMENT INDICATION;

CARDIAC SURGICAL PROCEDURES; HUMANS; MITRAL VALVE INSUFFICIENCY;

EID: 0037988917     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Olson LJ, Subramanian R, Ackermann DM, Orszulak TA, Edwards WD. Surgical pathology of the mitral valve: a study of 712 cases spanning 21 years. Mayo Clin Proc 1987;62:22-34.
2. Freed LA, Levy D, Levine RA, Larson MG, Evans JC, Fuller DL et al. Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med 1999;341:1-7.
3. Zuppiroli A, Rinaldi M, Kramer Fox R, Favilli S, Roman MJ, Devereux RB. Natural history of mitral valve prolapse. Am J Cardiol 1995;75:1028-32.
4. Rosario LB, Stevenson LW, Solomon SD, Lee RT, Reimold SC. The mechanism of decrease in dynamic mitral regurgitation during heart failure treatment: importance of reduction in the regurgitant orifice size. J Am Coll Cardiol 1998;32:1819-24.
5. Kono T, Sabbah HN, Rosman H, Alam M, Jafri S, Goldstein S. Left ventricular shape is the primary determinant of functional mitral regurgitation in heart failure. J Am Coll Cardiol 1992;20:1594-8.
6. Aikawa K, Sheehan FH, Otto CM, Coady K, Bashein G, Bolson EL. The severity of functional mitral regurgitation depends on the shape of the mitral apparatus: a 3D echo analysis. J Heart Valve Dis 2002;11:627-36.
7. Izumi S, Miyatake K, Beppu S, Park YD, Nagata S, Kinoshita N et al. Mechanism of mitral regurgitation in patients with myocardial infarction: a study using real-time 2D Doppler flow imaging and echocardiography. Circulation 1987;76:777-85.
8. Bonow RO, Carabello BA, deLeon AC, Edmunds LH, Jr., Fedderly BJ, Freed MD et al. ACC/AHA guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). J Am Coll Cardiol 1998;32: 1486-588.
9. Sellers RD, Levy MJ, Amplatz KW, Lillehi CW. Left retrograde cardioangiography in acquired cardiac disease. Am J Cardiol 1964;14:437-47.
10. Otto CM. Clinical practice. Evaluation and management of chronic mitral regurgitation. N Engl J Med 2001;345:740-6.
11. Delahaye JP, Gare JP, Viguier E, Delahaye F, de Gevigney G, Milon H. Natural history of severe mitral regurgitation. Eur Heart J 1991;12 Suppl BP5-9:5-9.
12. Waller BF, McManus BM, Roberts WC. Mitral valve stenosis produced by or worsened by active bacterial endocarditis. Chest 1982; 82:498-500.
13. Rosen SE, Borer JS, Hochreiter C, Supino P, Roman MJ, Devereux RB et al. Natural history of the asymptomatic/minimally symptomatic patient with severe mitral regurgitation secondary to mitral valve prolapse and normal right and left ventricular performance. Am J Cardiol 1994;74:374-80.
14. Enriquez-Sarano M, Basmadjian AJ, Rossi A, Bailey KR, Seward JB, Tajik AJ. Progression of mitral regurgitation: a prospective Doppler echocardiographic study. J Am Coll Cardiol 1999;34:1137-44.
15. Singh RG, Cappucci R, Kramer-Fox R, Roman MJ, Kligfield P, Borer JS et al. Severe mitral regurgitation due to mitral valve prolapse: risk factors for development, progression, and need for mitral valve surgery. Am J Cardiol 2000;85:193-8.
16. Marks AR, Choong CY, Sanfilippo AJ, Ferre M, Weyman AE. Identification of high-risk and low-risk subgroups of patients with mitral-valve prolapse. N Engl J Med 1989;320:1031-6.
17. Nishimura RA, McGoon MD, Shub C, Miller FA, Jr., Ilstrup DM, Tajik AJ. Echocardiographically documented mitral-valve prolapse. Long-term follow-up of 237 patients. N Engl J Med 1985;313:1305-9.
18. Grigioni F, Enriquez-Sarano M, Ling LH, Bailey KR, Seward JB, Tajik AJ et al. Sudden death in mitral regurgitation due to flail leaflet. J Am Coll Cardiol 1999;34: 2078-85.
19. Ling LH, Enriquez Sarano M, Seward JB, Tajik AJ, Schaff HV, Bailey KR et al. Clinical outcome of mitral regurgitation due to flail leaflet. N Engl J Med 1996;335: 1417-23.
20. Lehmann KG, Francis CK, Dodge HT. Mitral regurgitation in early myocardial infarction. Incidence, clinical detection, and prognostic implications. TIMI Study Group [published erratum appears in Ann Intern Med 1992;117:349]. Ann Intern Med 1992;117:10-7.
21. Tcheng JE, Jackman JD, Jr., Nelson CL, Gardner LH, Smith LR, Rankin JS et al. Outcome of patients sustaining acute ischemic mitral regurgitation during myocardial infarction. Ann Intern Med 1992;117:18-24.
22. Lamas GA, Mitchell GF, Flaker GC, Smith SC, Jr., Gersh BJ, Basta L et al. Clinical significance of mitral regurgitation after acute myocardial infarction. Survival and Ventricular Enlargement Investigators. Circulation 1997;96:827-33.
23. Grigioni F, Enriquez-Sarano M, Zehr KJ, Bailey KR, Tajik AJ. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation 2001;103:1759-64.
24. Blondheim DS, Jacobs LE, Kotler MN, Costacurta GA, Parry WR. Dilated cardiomyopathy with mitral regurgitation: decreased survival despite a low frequency of left ventricular thrombus. Am Heart J 1991;122(3 Pt 1):763-71.
25. Chatterjee K, Parmley WW, Swan HJ, Berman G, Forrester J, Marcus HS. Beneficial effects of vasodilator agents in severe mitral regurgitation due to dysfunction of subvalvar apparatus. Circulation 1973;48:684-90.
26. Levine HJ, Gaasch WH. Vasoactive drugs in chronic regurgitant lesions of the mitral and aortic valves. J Am Coll Cardiol 1996;28:1083-91.
27. Tischler MD, Rowan M, LeWinter MM. Effect of enalapril therapy on left ventricular mass and volumes in asymptomatic chronic, severe mitral regurgitation secondary to mitral valve prolapse. Am J Cardiol 1998;82:242-5.
28. Dujardin KS, Enriquez-Sarano M, Bailey KR, Seward JB, Tajik AJ. Effect of losartan on degree of mitral regurgitation quantified by echocardiography. Am J Cardiol 2001;87:570-6.
29. Carabello BA. Progress in mitral and aortic regurgitation. Prog Cardiovasc Dis 2001;43:457-75.
30. Enriquez Sarano M, Tajik AJ, Schaff HV, Orszulak TA, Bailey KR, Frye RL. Echocardiographic prediction of survival after surgical correction of organic mitral regurgitation. Circulation 1994;90:830-7.
31. Chua YL, Schaff HV, Orszulak TA, Morris JJ. Outcome of mitral valve repair in patients with preoperative atrial fibrillation. Should the maze procedure be combined with mitral valvuloplasty? J Thorac Cardiovasc Surg 1994;107:408-15.
32. Enriquez Sarano M, Schaff HV, Orszulak TA, Tajik AJ, Bailey KR, Frye RL. Valve repair improves the outcome of surgery for mitral regurgitation. A multivariate analysis. Circulation 1995;91:1022-8.